Ann Arbor, MI Treatment of ovarian cancer. The choice of treatment and the...
Health Information Treatment of ovarian cancer
Treatment of ovarian cancer
The choice of treatment and the long-term outcome (prognosis) of your
ovarian cancer depend on the
stage and grade of your cancer. Your age, overall health, and quality of life
must also be considered. Research studies are ongoing to find the best
treatment choices or combination of treatments that increase survival rates
without affecting your quality of life.
Your doctor confirms a diagnosis of ovarian cancer and determines its
spread (or stage) by taking
biopsies during
laparotomy surgery.
Laparoscopic surgery may be a choice for some women.
Talk with your doctor about your choices.
Surgery in early-stage ovarian cancer
Surgery in early-stage ovarian cancer determines both the stage and
grade of cancer. Surgery is also the first treatment for cancer. Surgical
staging means looking at different organs or tissues in the abdomen for cancer.
Surgery may include:
Taking a sample of
peritoneal fluid (peritoneal washings) from the
abdominal cavity, to look for cancer cells.
Removing and checking
the pelvic and aortic
lymph nodes, to see if the cancer has
spread.
Checking the abdominal organs and tissues for cancer cells.
Biopsies may be done.
Removing and checking the fatty tissue (omentum) attached to the
stomach and large intestine, to see if the cancer has spread.
An
appendectomy, which removes your appendix.
Women with stage IA or IB and grade 1 or 2 have the earliest stages
of cancer and have the best long-term outcomes when they are treated with
surgery. Chemotherapy may also be recommended. The 5-year survival rate-the
percentage of people who are still alive 5 years or longer after their
diagnosis-is as high as 93%.1
Women with stage I and grade 3 cancer are treated with both surgery
and chemotherapy. The 5-year survival rate is about 80%.2
Surgery in advanced-stage ovarian cancer
Surgery in advanced-stage ovarian cancer involves removing as much
of the cancer as possible. This is called tumor debulking or cytoreduction. The
uterus, omentum, and any areas of visible cancer are removed. This may include
surgery on the intestines, urinary system, or spleen, or scraping of the
diaphragm to remove all the cancer. The long-term outcome (prognosis) is better
if no cancer cells remain (there is no residual tumor).
Women with stage III cancer who are treated with surgery and
chemotherapy have a long-term survival rate of about 30% if most of the cancer
is removed in surgery.2
Women with stage IV cancer who are treated with surgery and
chemotherapy have a long-term survival rate of about 10%.2
Chemotherapy is usually started 1 to 4 weeks after surgery. The
standard medication therapy includes paclitaxel and carboplatin or
cisplatin.
Hysterectomy, bilateral salpingo-oophorectomy, periodic tumor
debulking (may include surgery on intestines, urinary system, or spleen, or
scraping the diaphragm), and chemotherapy
Citations
Brennan K, et al. (2007). Premalignant and malignant
disorders of the ovaries and oviducts. In AH DeCherney et al., eds.,
Current Diagnosis and Treatment Obstetrics and Gynecology, 10th ed., pp. 971-884. New York: McGraw-Hill.
Cannistra SA (2007). Gynecologic cancer. In DC Dale,
DD Federman, eds., ACP Medicine, section 12, chap. 10.
New York: WebMD.
National Comprehensive Cancer Network (2007). Ovarian
cancer. Clinical Practice Guidelines in Oncology, version 1. Available online:
http://www.nccn.org/professionals/physician_gls/PDF/ovarian.pdf.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Brennan K, et al. (2007). Premalignant and malignant
disorders of the ovaries and oviducts. In AH DeCherney et al., eds.,
Current Diagnosis and Treatment Obstetrics and Gynecology, 10th ed., pp. 971-884. New York: McGraw-Hill.
Cannistra SA (2007). Gynecologic cancer. In DC Dale,
DD Federman, eds., ACP Medicine, section 12, chap. 10.
New York: WebMD.
National Comprehensive Cancer Network (2007). Ovarian
cancer. Clinical Practice Guidelines in Oncology, version 1. Available online:
http://www.nccn.org/professionals/physician_gls/PDF/ovarian.pdf.